Hereditary Angioedema Market Size And Share

  • Report Code : TIPRE00005410
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2025 年至 2031 年遗传性血管性水肿市场规模、份额及预测

Buy Now

Hereditary Angioedema Market Report Hereditary Angioedema Market Scope and Analysis Hereditary Angioedema Market Size and Share

Hereditary Angioedema Market Report Analysis

Hereditary Angioedema Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BIOCRYST PHARMACEUTICALS, INC
  • CSL
  • Ionis Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp
  • Pharming Group N. V.
  • Sanofi N. V.
  • Shire plc.
  • Teva Pharmaceutical Industries, Ltd.
  • Attune Pharmaceuticals

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

By 药物
  • C1酯酶抑制剂
  • 激肽释放酶抑制剂
  • 缓激肽受体
  • 减毒雄激素等
By 给药途径
  • 皮下
  • 静脉
  • 口服
By 分销渠道
  • 医院药房
  • 零售药房
  • 电子商务
By 地理
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲